Publications
- Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group2020 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, First Faculty of Medicine
- Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma2018 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, First Faculty of Medicine, Second Faculty of Medicine
- Potential loss of prognostic significance of minimal residual disease assessment after R-CHOP-based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance2018 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, First Faculty of Medicine, Second Faculty of Medicine
- Recommendations for the diagnosis and treatment of chronic lymphocytic leukaemia (CLL) - 20182018 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies2017 | Faculty of Medicine in Hradec Králové
- Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia2016 | Faculty of Medicine in Hradec Králové
- Practical approach to management of chronic lymphocytic leukemia2016 | Faculty of Medicine in Hradec Králové
- Venous thromboembolism in patients with chronic lymphocytic leukemia2015 | Faculty of Medicine in Hradec Králové
- Prognostic relevance of angiopoietin-2, fibroblast growth factor-2 and endoglin mRNA expressions in chronic lymphocytic leukemia2014 | Faculty of Medicine in Hradec Králové
- Therapy of elderly/comorbid patients with chronic lymphocytic leukemia2013 | Faculty of Medicine in Hradec Králové
Loading network view...